Nothing
#' @title The R ONEST package
#' @name ONEST
#' @docType package
#' @description The ONEST software implements a statistical method in Reisenbichler et al. (2020[1]), to determine the minimum number of evaluators needed to estimate agreement involving a large number of raters. This method could be utilized by regulatory agencies, such as the FDA, when evaluating agreement levels of a newly proposed subjective laboratory test. Input to the program should be binary(1/0) pathology data, where “0” may stand for negative and “1” for positive. The example datasets in this software are from Rimm et al. (2017[2]) (the SP142 assay), and Reisenbichler et al. 2020. This program can run in R version 3.5.0 and above.
#'
#'
#' @references
#' [1] Reisenbichler ES, Han G, Bellizzi A, Bossuyt V, Brock J, Cole K, et al. Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer. Mod Pathol. 2020, DOI: 10.1038/s41379-020-0544-x; PMID: 32300181.
#'
#' [2] Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, et al. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017;3(8):1051-8, DOI: 10.1001/jamaoncol.2017.0013, PMID: 28278348.
NULL
#' Example dataset1
#'
#' A pathology reads dataset of triple negative breast cancer in Reisenbichler et al. (2020). A value of 0 means negative and a value of 1 means positive.
#'
#' \itemize{
#' \item columns : different raters
#' \item rows : different cases
#' }
#' @docType data
#' @keywords datasets
#' @name sp142_bin
#' @usage data('sp142_bin')
#' @references
#' [1] Reisenbichler ES, Han G, Bellizzi A, Bossuyt V, Brock J, Cole K, et al. Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer. Mod Pathol. 2020, DOI: 10.1038/s41379-020-0544-x; PMID: 32300181.
NULL
#' Example dataset2
#'
#' A pathology reads dataset of triple negative breast cancer in Reisenbichler et al. (2020). A value of 0 means negative and a value of 1 means positive.
#'
#' \itemize{
#' \item columns : different raters
#' \item rows : different cases
#' }
#' @docType data
#' @keywords datasets
#' @name sp263_bin
#' @usage data('sp263_bin')
#' @references
#' [1] Reisenbichler ES, Han G, Bellizzi A, Bossuyt V, Brock J, Cole K, et al. Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer. Mod Pathol. 2020, DOI: 10.1038/s41379-020-0544-x; PMID: 32300181.
NULL
#' Example dataset3
#'
#' NCCN SP142 stromal data from Rimm et al. (2017) used to illustrate the ONEST method.
#'
#' \itemize{
#' \item columns : different raters
#' \item rows : different cases
#' }
#' @docType data
#' @keywords datasets
#' @name NCCN_sp142
#' @usage data('NCCN_sp142')
#' @references
#' [1] Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, et al. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017;3(8):1051-8, DOI: 10.1001/jamaoncol.2017.0013, PMID: 28278348.
NULL
#' Example dataset4
#'
#' NCCN SP142 tumor data from Rimm et al. (2017) used to illustrate the ONEST method.
#'
#' \itemize{
#' \item columns : different raters
#' \item rows : different cases
#' }
#' @docType data
#' @keywords datasets
#' @name NCCN_sp142_t
#' @usage data('NCCN_sp142_t')
#' @references
#' [1] Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, et al. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017;3(8):1051-8, DOI: 10.1001/jamaoncol.2017.0013, PMID: 28278348.
NULL
#' Example dataset5
#'
#' NCCN 22c3 tumor data from Rimm et al. (2017) used to illustrate the ONEST method.
#'
#' \itemize{
#' \item columns : different raters
#' \item rows : different cases
#' }
#' @docType data
#' @keywords datasets
#' @name NCCN_22c3_t
#' @usage data('NCCN_22c3_t')
#' @references
#' [1] Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, et al. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017;3(8):1051-8, DOI: 10.1001/jamaoncol.2017.0013, PMID: 28278348.
NULL
#' Precomputed dataset
#'
#' A precomputed dataset only used by the ONEST_vignettes function to create the vignettes.
#'
#' \itemize{
#' \item columns : different permutations
#' \item rows : agreement percentage
#' }
#' @docType data
#' @keywords datasets
#' @name empirical
#' @usage data('empirical')
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.